The PIKNIC Trial: Targeting a Key Pathway in Advanced Breast Cancer

Published Liam Wise on Wed, 09/21/2022 - 09:57

VCCC Alliance Grand Round Breast Cancer

with Dr Peter Savas

7 September 2022


Hear the latest on the clinical outcomes and exploratory endpoints from the phase 2 clinical trial PIKNIC, which investigated Alpelisib monotherapy in patients with advanced breast cancer.

Dr Peter Savas
Peter MacCallum Cancer Centre

Dr Peter Savas is a medical oncologist, clinical trial investigator and clinician scientist at the Peter MacCallum Cancer Centre and Royal Melbourne Hospital. His reseach interests incude the breast cancer immune microenvironment, clinical and research applications of genomics and machine learning in digital histology.

VCCC Alliance Grand Rounds

The VCCC Alliance Research and Education (R&E Lead) Breast Cancer program has developed a learning environment where researchers and clinical care teams can share information to improve cancer outcomes.

The VCCC Alliance Breast Cancer Grand Round aims to provide a shared view of what is happening in the development of breast cancer care and is helping to stimulate discussion and collaborations among experienced and novice researchers and clinicians.

For further information on the program, please contact Jasper de Boer, VCCC Alliance Program Manager, Distributed Leadership jasper.deboer@unimelb.edu.au


The VCCC Alliance Breast Cancer Grand Round is targeted at a clinical audience and features open discussion about real cases and patients. While these cases are de-identified, the imagery, content and discussion can be graphic. It is not appropriate for consumer participants.

Course Details

Doctor Reading Imaging
Course type
Webinars
Duration
60 mins
Price
$0.00
Curriculum Area
Research (incl. Clinical Trials)
Leadership and Non-Technical Skills
Speciality
Early to mid career researcher
Senior researcher / scientist
Clinical trials
Breast
Clinical trials
Research

This course is brought to you by